• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

    2.100 -0.700 (-25.00%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 830,984
    Open 2.940
    Bid (Size) 2.090 (200)
    Ask (Size) 2.110 (500)
    Prev. Close 2.800
    Today's Range 2.070 - 3.046
    52wk Range 2.070 - 38.25
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -70.0%
    -70.0%
    1 Month
    -46.7%
    -46.7%
    3 Month
    -80.2%
    -80.2%
    6 Month
    -87.0%
    -87.0%
    1 Year
    -54.2%
    -54.2%

    More News

    Read More
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
    Via NewMediaWire
    Topics Fraud Law Enforcement Lawsuit
    News headline image
    QUANTUM BIOPHARMA DEADLINE FOR LEADERSHIP is February 23, 2026 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
    Via TheNewswire.com
    Topics Fraud Law Enforcement Lawsuit
    News headline image
    Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026 - Contact Kaplan Fox
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    Deadline to Lead in Securities Class Action Against Quantum Biopharma Ltd. (QNTM) is February 23, 2026 - Contact Kaplan Fox
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Quantum Biopharma Ltd. (QNTM) and Lead Plaintiff Deadline on February 23, 2026
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Securities Class Action Lawsuit - Deadline is February 23, 2026
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Alerts Quantum Biopharma Ltd. (QNTM) Investors to a Securities Class Action Lawsuit - Deadline is February 23, 2026
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    QUANTUM BIOPHARMA Investors are Encouraged to Contact Kaplan Fox Regarding the Securities Class Action Lawsuit
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    QUANTUM BIOPHARMA Investors are Encouraged to Contact Kaplan Fox Regarding the Securities Class Action Lawsuit
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Reminds Quantum Biopharma Ltd. (QNTM) Investors of a Securities Class Action Lawsuit
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Reminds Quantum Biopharma Ltd. (QNTM) Investors of a Securities Class Action Lawsuit
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Encourages Investors of Quantum Biopharma Ltd. (QNTM) to Contact the Firm Regarding the Securities Class Action Lawsuit
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Alerts Investors of Quantum Biopharma Ltd. (QNTM) to a Securities Class Action Lawsuit
    Via NewMediaWire
    Topics Law Enforcement Lawsuit
    News headline image
    Kaplan Fox Alerts Investors of Quantum Biopharma Ltd. (QNTM) to a Securities Class Action Lawsuit
    Via TheNewswire.com
    Topics Law Enforcement Lawsuit

    Frequently Asked Questions

    Is Quantum Biopharma Ltd. - Class B Subordinate Voting Shares publicly traded?
    Yes, Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is publicly traded.
    What exchange does Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trade on?
    Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The ticker symbol for Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is QNTM on the Nasdaq Stock Market
    What is the current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares?
    The current price of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares is 2.100
    When was Quantum Biopharma Ltd. - Class B Subordinate Voting Shares last traded?
    The last trade of Quantum Biopharma Ltd. - Class B Subordinate Voting Shares was at 03/11/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.